ArticleClinical and translational radiation oncology2022

The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation.

Alexander Rühle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.